Survey Finds Unexpectedly Low Market Prices for Injectable Generics; Industry to Accept 50% Rule

A health ministry survey found a surprisingly large gap between the reimbursement prices of injectable generics and their market prices, suggesting that a price war in the sector is accelerating in contradiction to claims made by a generic trade group,...read more